Cupid Ltd manufactures and exports male and female condoms, water-based lubricants, and diagnostic kits to global health agencies and governments, while rapidly expanding a domestic consumer brand for personal care and wellness products.
The company possesses a narrow moat derived from regulatory licenses, specifically being the first globally to hold WHO/UNFPA pre-qualification for both male and female condoms, which acts as a high barrier to entry for institutional tenders. This is corroborated by high net margins exceeding 20%, though the new FMCG segment is currently more competitive and lacks similar structural protection.
Management has shifted from a conservative, dividend-paying stance to aggressive reinvestment, including a major greenfield capacity expansion at Palava and a significant strategic investment in Baazar Style Retail to secure distribution.
The transition from a high-margin, niche regulatory monopoly into a commoditized FMCG player proved disastrous. Management's pivot from capital-light dividends to aggressive greenfield expansion and speculative retail investments drained the balance sheet, while the cash conversion cycle collapsed under the weight of inventory mismanagement. The dilution from preferential warrants and the distraction of managing a low-moat retail segment eroded the core business's profitability, leading to a permanent re-rating as the market realized the 'regulatory moat' did not extend to the competitive consumer landscape.
RichFakir rates Cupid Ltd's business quality as mediocre — 65/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Cupid Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Cupid Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Cupid Ltd's fair value is about ₹10 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →